Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

1.

Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy.

Dunphy FR, Harrison BR, Dunleavy TL, Rodriguez JJ, Hilton JG, Boyd JH.

Cancer. 1999 Oct 1;86(7):1362-7.

PMID:
10506726
[PubMed - indexed for MEDLINE]
2.

Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin.

Dunphy FR, Dunleavy TL, Harrison BR, Boyd JH, Varvares MA, Dunphy CH, Rodriguez JJ, McDonough EM, Minster JR, McGrady MD.

Cancer. 1997 Apr 15;79(8):1623-8.

PMID:
9118049
[PubMed - indexed for MEDLINE]
3.

Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.

de Campos E, Radford J, Steward W, Milroy R, Dougal M, Swindell R, Testa N, Thatcher N.

J Clin Oncol. 1995 Jul;13(7):1623-31.

PMID:
7602351
[PubMed - indexed for MEDLINE]
4.

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E.

Cancer. 1995 Dec 1;76(11):2319-29.

PMID:
8635038
[PubMed - indexed for MEDLINE]
5.

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D.

Gynecol Oncol. 2001 Jun;81(3):485-9.

PMID:
11371143
[PubMed - indexed for MEDLINE]
6.

Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.

Tsuboi M, Ezaki K, Tobinai K, Ohashi Y, Saijo N.

Jpn J Clin Oncol. 2009 Mar;39(3):163-8. doi: 10.1093/jjco/hyn151. Epub 2009 Jan 22.

PMID:
19164318
[PubMed - indexed for MEDLINE]
Free Article
7.

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.

Oberhoff C, Neri B, Amadori D, Petry KU, Gamucci T, Rebmann U, Nowrousian MR, Voigtmann R, Monfardini S, Armand JP, Herrmann R, Netter-Pinon J, Tubiana-Mathieu N, Zwierzina H.

Ann Oncol. 1998 Mar;9(3):255-60.

PMID:
9602258
[PubMed - indexed for MEDLINE]
Free Article
8.

Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.

Del Mastro L, Venturini M, Lionetto R, Garrone O, Melioli G, Pasquetti W, Sertoli MR, Bertelli G, Canavese G, Costantini M, Rosso R.

J Clin Oncol. 1997 Jul;15(7):2715-21.

PMID:
9215845
[PubMed - indexed for MEDLINE]
9.

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E Jr, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.

Cancer. 2002 Jul 15;95(2):322-30.

PMID:
12124833
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.

Abbrederis K, Bassermann F, Schuhmacher C, Voelter V, Busch R, Roethling N, Sendler A, Siewert JR, Peschel C, Lordick F.

Ann Thorac Surg. 2006 Jul;82(1):293-7.

PMID:
16798232
[PubMed - indexed for MEDLINE]
12.

Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.

Mantovani G, Ghiani M, Curreli L, Maccio A, Massa D, Succu G, Lai P, Massa E, Mudu MC, Astara G.

Oncol Rep. 1999 Mar-Apr;6(2):421-6.

PMID:
10023014
[PubMed - indexed for MEDLINE]
13.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.

Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.

Blood. 1995 Dec 15;86(12):4446-53.

PMID:
8541533
[PubMed - indexed for MEDLINE]
Free Article
14.

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Shin DM, Khuri FR, Glisson BS, Ginsberg L, Papadimitrakopoulou VM, Clayman G, Lee JJ, Ang KK, Lippman SM, Hong WK.

Cancer. 2001 Apr 1;91(7):1316-23.

PMID:
11283932
[PubMed - indexed for MEDLINE]
15.

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.

Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, Berthet P, Breau JL, Lianes P, Nicholson M, Ardizzoni A, Chemaissani A, Bogaerts J, Gallant G.

Ann Oncol. 2002 Oct;13(10):1539-49.

PMID:
12377641
[PubMed - indexed for MEDLINE]
Free Article
16.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

Case DC Jr, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, et al.

J Natl Cancer Inst. 1993 May 19;85(10):801-6.

PMID:
8487324
[PubMed - indexed for MEDLINE]
17.

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.

Rosen FR, Haraf DJ, Kies MS, Stenson K, Portugal L, List MA, Brockstein BE, Mittal BB, Rademaker AW, Witt ME, Pelzer H, Weichselbaum RR, Vokes EE.

Clin Cancer Res. 2003 May;9(5):1689-97.

PMID:
12738722
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.

Kurz Ch, Marth Ch, Windbichler G, Lahousen M, Medl M, Vavra N, Sevelda P.

Gynecol Oncol. 1997 Jun;65(3):461-6.

PMID:
9190976
[PubMed - indexed for MEDLINE]
20.

Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.

Ots PM, Pérez AR, Carrizosa CL, Ocaña CV, de Dios Sáez Garrido J, Delgado Pérez JM.

Clin Transl Oncol. 2005 Dec;7(11):486-92.

PMID:
16373059
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk